← Evidence map

TrialCancer2015

Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.

Sylvia M Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

57 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25250858